[1] Conrad N, Judge A, Tran J, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet 2018; 391: 572-580. doi:  10.1016/S0140-6736(17)32520-5
[2] Savarese G, Lund LH. Global public health burden of heart failure. Card Fail Rev 2017; 3: 7-11. doi:  10.15420/cfr.2016:25:2
[3] Hao G, Wang X, Chen Z, et al. Prevalence of heart failure and left ventricular dysfunction in China: the China Hypertension Survey, 2012-2015. Eur J Heart Fail 2019; 21: 1329-1337. doi:  10.1002/ejhf.1629
[4] Gu DF, Huang GY, He J, et al.[Investigation of prevalence and distributing feature of chronic heart failure in Chinese adult population]. Zhonghua Xin Xue Guan Bing Za Zhi 2003; 31: 3-6.[In Chinese]. http://europepmc.org/abstract/CBA/583939
[5] Azad N, Lemay G. Management of chronic heart failure in the older population. J Geriatr Cardiol 2014; 11: 329-337. http://www.cqvip.com/QK/88644X/20144/664107778.html
[6] Tuegel C, Bansal N. Heart failure in patients with kidney disease. Heart 2017; 103: 1848-1853. doi:  10.1136/heartjnl-2016-310794
[7] House AA, Wanner C, Sarnak MJ, et al. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int 2019; 95: 1304-1317. doi:  10.1016/j.kint.2019.02.022
[8] World Health Organization. China country assessment report on ageing and health. World Health Organization of ageing and life-course Web site. https://www.who.int/ageing/publications/china-country-assessment/en/ (accessed November 20, 2019).
[9] Wang Z, Zhang L, Chen Z, et al. Survey on prevalence of hypertension in China: background, aim, method and design. Int J Cardiol 2014; 174: 721-723. doi:  10.1016/j.ijcard.2014.03.117
[10] Dong Y, Wang Z, Chen Z, et al. Comparison of visceral, body fat indices and anthropometric measures in relation to chronic kidney disease among Chinese adults from a large scale cross-sectional study. BMC Nephrol 2018; 19: 40. doi:  10.1186/s12882-018-0837-1
[11] Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463. doi:  10.1016/j.echo.2005.10.005
[12] Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10: 165-193.
[13] Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-2200. doi:  10.1093/eurheartj/ehw128
[14] Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442. doi:  10.1093/eurheartj/ehn309
[15] van Riet EE, Hoes AW, Wagenaar KP, et al. Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review. Eur J Heart Fail 2016; 18: 242-252. doi:  10.1002/ejhf.483
[16] Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1-39.e14. doi:  10.1016/j.echo.2014.10.003
[17] Joint committee for guideline revision. 2016 Chinese guidelines for the management of dyslipidemia in adults. J Geriatr Cardiol 2018; 15: 1-29. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=lnxzbxzz-e201801001
[18] Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 2013; 158: 825-830. doi:  10.7326/0003-4819-158-11-201306040-00007
[19] Chen CM, Kong LZ, for China Obesity Problem Working Group. In Chinese adults guidelines for the prevention and control of overweight and obesity, People's Medical Publishing House: Beijing, China, 2006.
[20] Census Office of The State Council of China, Division of Population and Employment Statistics, National Bureau of Statistics of China. In Tabulation on the 2010 population census on the People's Republic of China[Online]; China Statistics Press: Beijing, China, 2012. https://www.stats.gov.cn/tjsj/pcsj/rkpc/6rp/indexch.htm (accessed May 20, 2012).
[21] Segall L, Nistor I, Covic A. Heart failure in patients with chronic kidney disease: a systematic integrative review. Biomed Res Int 2014; 2014: 937398. http://downloads.hindawi.com/journals/bmri/aip/937398.pdf
[22] Kottgen A, Russell SD, Loehr LR, et al. Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol 2007; 18: 1307-1315. doi:  10.1681/ASN.2006101159
[23] He J, Shlipak M, Anderson A, et al. Risk factors for heart failure in patients with chronic kidney disease: the CRIC (Chronic Renal Insufficiency Cohort) study. J Am Heart Assoc 2017; 6: e005336. http://europepmc.org/abstract/MED/28515118
[24] Avery CL, Loehr LR, Baggett C, et al. The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 2012; 60: 1640-1646. doi:  10.1016/j.jacc.2012.07.022
[25] Mahmood SS, Wang TJ. The epidemiology of congestive heart failure: the Framingham Heart Study perspective. Glob Heart 2013; 8: 77-82. doi:  10.1016/j.gheart.2012.12.006
[26] Kamimura D, Cain LR, Mentz RJ, et al. Cigarette smoking and incident heart failure: insights from the Jackson Heart Study. Circulation 2018; 137: 2572-2582. doi:  10.1161/CIRCULATIONAHA.117.031912
[27] Ahmed AA, Patel K, Nyaku MA, et al. Risk of heart failure and death after prolonged smoking cessation: role of amount and duration of prior smoking. Circ Heart Fail 2015; 8: 694-701. doi:  10.1161/CIRCHEARTFAILURE.114.001885
[28] Gopal DM, Kalogeropoulos AP, Georgiopoulou VV, et al. Cigarette smoking exposure and heart failure risk in older adults: the Health, Aging, and Body Composition Study. Am Heart J 2012; 164: 236-242. doi:  10.1016/j.ahj.2012.05.013
[29] Gluba-Brzózka A, Michalska-Kasiczak M, Franczyk-Skóra B, et al. Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids Health Dis 2014; 13: 135. doi:  10.1186/1476-511X-13-135
[30] Otsuka T, Suzuki M, Yoshikawa H, et al. Left ventricular diastolic dysfunction in the early stage of chronic kidney disease. J Cardiol 2009; 54: 199-204. doi:  10.1016/j.jjcc.2009.05.002
[31] Dounaevskaia V, Yan AT, Charytan D, et al. The management of left ventricular systolic dysfunction in patients with advanced chronic kidney disease. J Nephrol 2011; 24: 41-49.